551 related articles for article (PubMed ID: 11904112)
21. Fluconazole prophylaxis and Candida fungemia in neutropenic children with malignancies.
Cesaro S; Rossetti F; Perilongo G; Rossi L; Zanesco L
Haematologica; 1993; 78(4):249-51. PubMed ID: 8294059
[TBL] [Abstract][Full Text] [Related]
22. [Epidemiology of fungemia in a university hospital; therapeutic incidence].
Pavese P; Brion JP; Lebeau B; Grillot R; Ambroise-Thomas P
Pathol Biol (Paris); 1999 May; 47(5):579-83. PubMed ID: 10418046
[TBL] [Abstract][Full Text] [Related]
23. Candidemia before and during the fluconazole era: prevalence, type of species and approach to treatment in a tertiary care community hospital.
Baran J; Muckatira B; Khatib R
Scand J Infect Dis; 2001; 33(2):137-9. PubMed ID: 11233850
[TBL] [Abstract][Full Text] [Related]
24. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
[TBL] [Abstract][Full Text] [Related]
25. Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group.
Phillips P; Shafran S; Garber G; Rotstein C; Smaill F; Fong I; Salit I; Miller M; Williams K; Conly JM; Singer J; Ioannou S
Eur J Clin Microbiol Infect Dis; 1997 May; 16(5):337-45. PubMed ID: 9228472
[TBL] [Abstract][Full Text] [Related]
26. Initial antifungal strategy does not correlate with mortality in patients with candidemia.
Murri R; Scoppettuolo G; Ventura G; Fabbiani M; Giovannenze F; Taccari F; Milozzi E; Posteraro B; Sanguinetti M; Cauda R; Fantoni M
Eur J Clin Microbiol Infect Dis; 2016 Feb; 35(2):187-93. PubMed ID: 26634352
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for fluconazole-resistant candidemia.
Garnacho-Montero J; Díaz-Martín A; García-Cabrera E; Ruiz Pérez de Pipaón M; Hernández-Caballero C; Aznar-Martín J; Cisneros JM; Ortiz-Leyba C
Antimicrob Agents Chemother; 2010 Aug; 54(8):3149-54. PubMed ID: 20498325
[TBL] [Abstract][Full Text] [Related]
28. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.
Safdar A; Hanna HA; Boktour M; Kontoyiannis DP; Hachem R; Lichtiger B; Freireich EJ; Raad II
Cancer; 2004 Dec; 101(12):2859-65. PubMed ID: 15529309
[TBL] [Abstract][Full Text] [Related]
29. Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007.
Poikonen E; Lyytikäinen O; Anttila VJ; Koivula I; Lumio J; Kotilainen P; Syrjälä H; Ruutu P
BMC Infect Dis; 2010 Oct; 10():312. PubMed ID: 21029444
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology and treatment of hematogenous candidiasis: a Brazilian perspective.
Colombo AL
Braz J Infect Dis; 2000 Jun; 4(3):113-8. PubMed ID: 10934493
[TBL] [Abstract][Full Text] [Related]
31. Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes.
Pagano L; Antinori A; Ammassari A; Mele L; Nosari A; Melillo L; Martino B; Sanguinetti M; Equitani F; Nobile F; Carotenuto M; Morra E; Morace G; Leone G
Eur J Haematol; 1999 Aug; 63(2):77-85. PubMed ID: 10480286
[TBL] [Abstract][Full Text] [Related]
32. Candidemia in immunocompromised patients.
Meunier F; Aoun M; Bitar N
Clin Infect Dis; 1992 Mar; 14 Suppl 1():S120-5. PubMed ID: 1562683
[TBL] [Abstract][Full Text] [Related]
33. Secular trends of candidemia over 12 years in adult patients at a tertiary care hospital.
Garbino J; Kolarova L; Rohner P; Lew D; Pichna P; Pittet D
Medicine (Baltimore); 2002 Nov; 81(6):425-33. PubMed ID: 12441899
[TBL] [Abstract][Full Text] [Related]
34. Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links.
Sendid B; Cotteau A; François N; D'Haveloose A; Standaert A; Camus D; Poulain D
BMC Infect Dis; 2006 May; 6():80. PubMed ID: 16670011
[TBL] [Abstract][Full Text] [Related]
35. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
Magill SS; Swoboda SM; Shields CE; Colantuoni EA; Fothergill AW; Merz WG; Lipsett PA; Hendrix CW
Ann Surg; 2009 Apr; 249(4):657-65. PubMed ID: 19300221
[TBL] [Abstract][Full Text] [Related]
36. Changing epidemiology of candidemia in a medical center in middle Taiwan.
Hii IM; Chang HL; Lin LC; Lee YL; Liu YM; Liu CE; Chen CH; Cheng YR; Chang CY
J Microbiol Immunol Infect; 2015 Jun; 48(3):306-15. PubMed ID: 24113067
[TBL] [Abstract][Full Text] [Related]
37. Invasive candidiasis in cancer patients: observations from a randomized clinical trial.
DiNubile MJ; Hille D; Sable CA; Kartsonis NA
J Infect; 2005 Jun; 50(5):443-9. PubMed ID: 15907554
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
[TBL] [Abstract][Full Text] [Related]
39. Nosocomial candidaemias due to species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution.
Krcmery V; Mrazova M; Kunova A; Grey E; Mardiak J; Jurga L; Sabo A; Sufliarsky J; Sevcikova L; Sorkovska D; West D; Trupl J; Novotny J; Mateicka F
Support Care Cancer; 1999 Nov; 7(6):428-31. PubMed ID: 10541986
[TBL] [Abstract][Full Text] [Related]
40. Candida lusitaniae: a cause of breakthrough fungemia in cancer patients.
Minari A; Hachem R; Raad I
Clin Infect Dis; 2001 Jan; 32(2):186-90. PubMed ID: 11170906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
